60 Degrees Pharmaceuticals (SXTP) Preferred Shares (2023 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Preferred Shares of $9.6 million for Q1 2026, little changed year-over-year from $9.6 million in Q1 2025, and little changed quarter-over-quarter from $9.6 million in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Preferred Shares (2023 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Preferred Shares for 4 consecutive years, with $9.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Preferred Shares changed 0.0% year-over-year to $9.6 million; the TTM figure through Mar 2026 stood at $9.6 million (changed 0.0% YoY), while the FY2025 annual figure was $9.6 million, changed 0.0% from the prior year.
- Preferred Shares held at $9.6 million in Q1 2026 per SXTP's latest filing, from $9.6 million in the prior quarter.
- Across five years, Preferred Shares topped out at $9.9 million in Q3 2023 and bottomed at $9.6 million in Q3 2024.
- Historically, Preferred Shares has averaged $9.7 million across 4 years, with a median of $9.6 million in 2024.
- Annual changes were most pronounced in 2024 — Preferred Shares retreated 2.95% — and 2025, when it changed 0.0%.
- 60 Degrees Pharmaceuticals' Preferred Shares stood at $9.9 million in 2023, then decreased by 2.95% to $9.6 million in 2024, then changed by 0.0% to $9.6 million in 2025, then changed by 0.0% to $9.6 million in 2026.
- Business Quant data shows SXTP's Preferred Shares at $9.6 million in Q1 2026, $9.6 million in Q4 2025, and $9.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 | 9.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.57 Mn |
| Dec 31, 2025 | 9.57 Mn |
| Sep 30, 2025 | 9.57 Mn |
| Jun 30, 2025 | 9.57 Mn |
| Mar 31, 2025 | 9.57 Mn |
| Dec 31, 2024 | 9.57 Mn |
| Sep 30, 2024 | 9.57 Mn |
| Jun 30, 2024 | 9.86 Mn |
| Mar 31, 2024 | 9.86 Mn |
| Dec 31, 2023 | 9.86 Mn |
| Sep 30, 2023 | 9.86 Mn |